In addition, in the present study we analyzed the prognostic role of genetic variants of the p14ARF/MDM2/TP53 pathway in ESCC patients who had not received neoadjuvant therapy mainly because chemotherapy and/or radiation may have an impact on the genetic variants in the tumor tissue. Here, MDM2 is linked to neoplasm.